VSL#3
Dietary Supplementone sachet per day, for 45 consecutive days
Other names: probiotics, VSL phrma,USA
NCT Number: NCT00794924
Probiotics have been shown to reduce the rate of diarrhea and constipation. The purpose of this study was to investigate if probiotics could improve outcome of hospitalized orthopedic elderly patients.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
The patients were divided into two groups. One received probiotics for 45 days and the second received placebo. The patients had a clinical and epidemiological as well as nutritional assessment. They were followed-up as for their bowel movements, abdominal pain and nosocomial infections and for the incidence of helicobacter pylori and clostridiume difficille diarrhea.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
one sachet per day, for 45 consecutive days
Other names: probiotics, VSL phrma,USA
one sachet per day, for 45 consecutive days
Time frame: 45 days of measuring the outcome
Gastrointestinal motility was assessed by the number of days a patient was constipated or had diarrhea.
Time frame: 45 days
Kaplan-Harzfeld Medical Center
Other
Effects of Commercially Available Probiotics on Hospital Outcome
Acronym: PROAGE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07230821
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Del Mar, California, United States
View Trial DetailsNCT03499808
Amorphous, Eosinophilic, and Acellular Deposit, Amyloidosis
Anchorage, Alaska, United States
View Trial DetailsNCT06285851
Bleeding Gastric, Colic
Calgary, Alberta, Canada
View Trial DetailsNCT05247333
Acne, Acne Vulgaris
Madrid, Spain
View Trial Details